Bluejay Diagnostics (BJDX) Shares Outstanding (2020 - 2026)

Bluejay Diagnostics (BJDX) has 5 years of Shares Outstanding (Entity) data on file, last reported at $2416.0 in Q2 2024.

• For the quarter ending Q2 2024, Shares Outstanding (Entity) rose 277.5% year-over-year to $2416.0; the trailing twelve-month figure through Jun 2024 stood at $2416.0 (up 277.5% YoY), and the FY2023 full-year result was $774.0, up 22.47% from the prior year.
• Shares Outstanding (Entity) advanced to $2416.0 in Q2 2024, from $1680.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $2416.0 in Q2 2024 to a low of $98.0 in Q3 2020.
• A 5-year average of $654.06 and a median of $630.0 in 2022 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 542.86% in 2022 and climbed 1.43% in 2023, its largest moves.
• Tracing BJDX's Shares Outstanding (Entity) over 5 years: stood at $98.0 in 2020, then surged by 171.43% to $266.0 in 2021, then surged by 137.59% to $632.0 in 2022, then increased by 22.47% to $774.0 in 2023, then soared by 212.14% to $2416.0 in 2024.
• Business Quant data shows BJDX's Shares Outstanding (Entity) at $2416.0 in Q2 2024, $1680.0 in Q1 2024, and $774.0 in Q4 2023.